No Detail Found!

Comparison of Serum Lipid Profile in Non Alcoholic Fatty Liver Disease.

Author(s)
Atif Latif Pakistan Naval Ship (PNS)ShifaHospital, Karachi Pakistan
Syed Raza Jafer Pakistan Naval Ship (PNS)ShifaHospital, Karachi Pakistan
Nisar Ahmed Pakistan Naval Ship (PNS)ShifaHospital, Karachi Pakistan
Mazhar Shafiq Pakistan Naval Ship (PNS)ShifaHospital, Karachi Pakistan
Kumari Sapna Pakistan Naval Ship (PNS)ShifaHospital, Karachi Pakistan
Qurrat-Ul-Ain Pakistan Naval Ship (PNS)ShifaHospital, Karachi Pakistan
Abstract
Objective: To compare serum lipid profile in different ultrasonographic grades of non alcoholic fatty liver disease (NAFLD). Study Design: Cross sectional study. Place and Duration of Study: PNS SHIFA hospital, Karachi, from Oct 2015 to Jul 2016. Material and Methods: Seventy three adults of either gender were consecutively inducted after diagnosis of non alcoholic fatty liver disease (NAFLD) on ultrasonography (USG). These individuals were further classified into grade I, II and III of NAFLD depending on US findings. Fasting blood sample of all the subjects was analyzed for serum fasting lipid profile comprising of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C). Serum non HDL cholesterol (nonHDL-C) was calculated by subtracting HDL-C from TC. Results: Among 73 subjects with NAFLD, 42.5%, 37% and 20.5% had grade I, II and III NAFLD respectively. All parameters showed significant increase in frequency of abnormal results with increasing grade of NAFLD except TG. Significant difference was found in mean TC (p=0.000), LDL-C (p=0.000), HDL-C (p=0.005) and nonHDL-C (p=0.000) between grades of NAFLD. Post hoc analysis revealed that only mean nonHDL-C was significantly different amongst all the grades of NAFLD. Conclusion: The increasing severity of NAFLD was found associated with increased frequency of dyslipidemia. Though most frequent dyslipidemia in NAFLD was low serum HDL-C followed by hypertriglyceridemia, only serum nonHDL-C was statistically different amongst all the grades of NAFLD.
Publication Details
Page(s) 930-935
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 67, Issue: 6, Year: 2017

Request the full text from PASTIC

References
ChalasaniN,YounossiZ,LavineJE,DiehlAM,BruntEM,CusiK,,2012,The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association,Hepatology,55,2005,23
LaBrecqueDR,AbbasZ,AnaniaF,FerenciP,KhanAG,GohKL,,2014,World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis,J Clin Gastroenterol,48,467,73
NiazA,AliZ,NayyarS,FatimaN.,,2011,Prevalence of NAFLD in healthy and young male individuals,ISRN Gastroenterol,,363546,
ParkashO,HamidS.,,2013,Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease,J Pak Med Assoc,63,95,9
BedossaP,,2013,Current histological classification of NAFLD: strength and limitations,Hepatol Int,7,765,70
MahalingDU,BasavaraMM,BikaAJ,,2013,Comparison of lipid profile in different grades of non-alcoholic fatty liver disease diagnosed on ultrasound,Asian Pac J Trop Biomed,3,907,12
Fon TacerK,Rozman D. Nonalcoholic,,2011,Fatty liver disease: focus on lipoprotein and lipid deregulation,J Lipids,,783976,
AdamsLA,LympJF,St SauverJ,SandersonSO,LindorKD,FeldsteinA,,2005,The natural history of nonalcoholic fatty liver disease: A population-based cohort study,Gastroenterology,129,113,21
AlamS,MustafaG,AlamM,AhmadN.,,2016,Insulin resistance in development and progression of nonalcoholic fatty liver disease,World J Gastrointest Pathophysiol,7,211,7
Dam-LarsenS,FranzmannM,AndersenIB,ChristoffersenP,JensenLB,SørensenTI,,2004,et al. Long term prognosis of fatty liver: Risk of chronic liver disease and death,Gut,53,750,5
EkstedtM,FranzenLE,MathiesenUL,ThoreliusL,HolmqvistM,BodemarG,,2006,Long-term follow-up of patients with NAFLD and elevated liver enzymes,Hepatology,44,865,73
DunnW,XuR,WingardD,RogersC,AnguloP,YounossiZM,,2008,Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study,Am J Gastroenterol,103,2263,71
RafiqN,BaiCH,FangY,SrishordM,McCulloughA,GramlichT,,2009,Long-term follow-up of patients with non-alcoholic fatty liver,Clin Gastroenterol Hepatol,7,234,8
Dam-LarsenS,BeckerU,FranzmannMB,LarsenK,ChristoffersenP,BendtsenF,,2009,Final results of a long-term, clinical follow-up in fatty liver patients,Sc and J Gastroenterol,44,1236,43
StepanovaM,RafiqN,YounossiZM,,2010,Components of metabolic syndrome as independent predictors of mortality in chronic liver disease: A population-based study,Gut,59,1410,5
SenA,KumarJ,MisraRP,UddinM,ShuklaPC,,2013,Lipid profile of patients having non-alcoholic fatty liver disease as per ultrasound findings in north Indian population: A retrospective observational study,J Med Allied Sci,3,59,62
AlkassabanyYM,FarghalyAG,El-GhitanyEM,,2014,Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: A hospital-based study in Alexandria, Egypt,Arab J Gastroenterol,15,76,81
ChatrathH,VuppalanchiR,ChalasaniN.,,2012,Dyslipidemia in patients with nonalcoholic fatty liver disease,Semin Liver Dis,32,22,9
JellingerPS,SmithDA,MehtaAE,GandaO,HandelsmanY,RodbardHW,,2012,American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary,Endocr Pract,18,269,93
HassanK,BhallaV,El RegalME,A-KaderHH,,2014,Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic,World J Gastroenterol,20,12082,101
BanoU,GondalM,MoenS,,2008,Evaluation of risk factors of non alcoholic fatty liver disease (NAFLD) in a tertiary care hospital at Rawalpindi, Pakistan: a local experience,J Postgrad Med Inst,22,189,95
SiddiquiMS,FuchsM,IdowuM,LuketicVA,BoyettS,SargeantC,,2015,Severity of Nonalcoholic Fatty Liver Disease and progression to cirrhosis associate with atherogenic lipoprotein profile,Clin Gastroenterol Hepatol,13,1000,8
0

Citations

0

Downloads

61

Views